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ABSTRACT
Objectives: Many studies have investigated
multimorbidity, whose prevalence varies according to
settings and data sources. However, few studies on
this topic have been conducted in Italy, a country with
universal healthcare and one of the most aged
populations in the world. The aim of this study was to
estimate the prevalence of multimorbidity in a Northern
Italian region, to investigate its distribution by age,
gender and citizenship and to analyse the correlations
of diseases.
Design: Cross-sectional study based on administrative
data.
Setting: Emilia-Romagna, an Italian region with ∼4.4
million inhabitants, of which almost one-fourth are
aged ≥65 years.
Participants: All adults residing in Emilia-Romagna
on 31 December 2012. Hospitalisations, drug
prescriptions and contacts with community mental
health services from 2003 to 2012 were traced to
identify the presence of 17 physical and 9 mental
health disorders.
Primary and secondary outcome measures:
Descriptive analysis of differences in the prevalence of
multimorbidity in relation to age, gender and
citizenship. The correlations of diseases were analysed
using exploratory factor analysis.
Results: The study population included 622 026 men
and 751 011women, with a mean age of 66.4 years.
Patients with multimorbidity were 33.5% in 75 years
and >60% among patients aged ≥90 years; among
patients aged ≥65 years, the proportion of
multimorbidity was 39.9%. After standardisation by
age and gender, multimorbidity was significantly more
frequent among Italian citizens than among
immigrants. Factor analysis identified 5 multimorbidity
patterns: (1) psychiatric disorders, (2) cardiovascular,
renal, pulmonary and cerebrovascular diseases, (3)
neurological diseases, (4) liver diseases, AIDS/HIV and
substance abuse and (5) tumours.
Conclusions: Multimorbidity was highly prevalent in
Emilia-Romagna and strongly associated with age. This
finding highlights the need for healthcare providers to
adopt individualised care plans and ensure continuity
of care.
INTRODUCTION
In the past decades, multimorbidity, that is,
the co-occurrence of at least two chronic
conditions in one individual, has increasingly
become a challenge for healthcare services.1
Barnett et al2 estimated that, in Scotland,
almost one-fourth of all individuals, and
more than half of those with a chronic dis-
order, have multimorbidity. Multimorbidity is
more common among women and older
people,3 and is now considered the most
prevalent chronic health condition in the
overall population.4
It has been reported that people with mul-
timorbidity have poorer quality of life and
worse outcomes,5 and are frequent users of
healthcare services.6 In fact, the treatment of
multimorbidity results in high healthcare
costs and involves multiple professionals.
However, although many clinical guidelines
are available for the management of specific
chronic conditions, such as hypertension,
diabetes and heart failure, there is a lack of
evidence-based integrated treatments for
patients with multiple diseases.7 So, the treat-
ment of multimorbidity would require a hol-
istic approach to cope with patients’ complex
healthcare needs,8 9 and continuity of care
Strengths and limitations of this study
▪ This is the first study conducted in Italy to
assess the prevalence and pattern of multimor-
bidity and its distribution by age, gender and
citizenship.
▪ This is a population-based study comprising all
adults residing in the region of Emilia-Romagna,
a large Italian region with ∼4.4 million inhabi-
tants, of which almost one-fourth are aged
≥65 years and >10% are foreign citizens.
▪ The use of administrative data may have under-
estimated multimorbidity, as they do not include
primary care data.
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should be ensured to multimorbid patients.10 11 Primary
care has thus a key role in managing multimorbidity, as
it is person-focused rather than disease-focused, it is con-
tinuous over time and co-ordinates specialist care when
necessary.12 13
Many studies were conducted to investigate the preva-
lence of multimorbidity in different countries, but
results may differ according to the diseases considered,
the age of the population, settings and data sources.3 Of
note, few studies on this topic have been conducted in
Italy, a country with universal healthcare and one of the
most aged populations in the world.
The aim of the present study was to estimate the
prevalence of multimorbidity in Emilia-Romagna (Italy),
to investigate its distribution by age, gender and citizen-
ship and to analyse the correlations of diseases.
METHODS
Study design and participants
This cross-sectional study is based on demographic and
clinical data retrieved from five data sources linked
using the patient’s identification code:
1. The hospital discharge record (HDR) database,
which includes demographic characteristics, admis-
sion referral source, admission and discharge dates,
main diagnosis, up to five secondary diagnoses, up to
six interventions (identified using the ICD-9-CM
coding system) and discharge status. HDRs are sent
by all public and private hospitals to the Regional
Authority and on a regular basis from the Regional
Authority to the Ministry of Health after data quality
control. Since 1995, the diagnosis-related group
system has been systematically used to allocate funds
to hospitals and to monitor quality of care and
outcomes.
2. The mental health information system. This register
was implemented in 2005 for administrative and clin-
ical epidemiological purposes. All adult patients who
have at least one contact with the community mental
health centres (CMHCs) are recorded in the data-
base, which includes demographic characteristics, the
ICD-9-CM diagnosis and information of each type of
intervention administered.
3. Residential mental healthcare discharge records, a
database active since 2008 that includes mandatory
information on patients discharged from non-profit
or accredited private facilities, that is, admission and
discharge dates, main diagnosis and discharge status.
Accredited facilities are private hospitals where fees
are reimbursed by the Italian National Health Service
if the patient is an official resident in Italy.
4. The outpatient pharmaceutical database, which
contains information on patients’ gender and age,
prescriptions (substance name, ATC System code—
V.2013, trade name, date of prescription filling and
number of packages) and prescribers. This register
includes drugs reimbursed by the healthcare system
that are prescribed by the general practitioner or a
specialist, or directly delivered by the hospital
pharmacies.
5. The regional mortality register database, which con-
tains information on patients’ demographic character-
istics as well as date, place and cause of death. This
database was used to identify patients who alive on the
prevalence date.
The study population comprised of all adults (aged
≥18 years) who were residing in the region of Emilia-
Romagna on 31 December 2012. Emilia-Romagna is a
Northern Italian region with ∼4.4 million inhabitants, of
which almost one-fourth are aged ≥65 years and >10%
are foreign citizens—one of the highest proportion
among all Italian regions.
In Italy, all residents are registered with the National
Health Service that provides uniform and comprehen-
sive care. Under the Italian Constitution and its recent
modification (2001), the State has exclusive power to set
the ‘essential levels of care’ for all residents throughout
the country, whereas the regions have responsibility
for the organisation and administration of publicly
financed healthcare. Primary healthcare is provided by
general practitioners remunerated on a capitation base/
formula; they are in charge of providing care and assess
patients’ needs, order diagnostic procedures, prescribe
drugs and refer patients to specialists and hospitals.
They thus act as ‘gatekeepers’ for the system and ensure
continuity of care to patients with chronic diseases.
Foreign citizens with regular stay permit are entitled
to registration with the Italian National Health Service
and to the same treatment as Italian citizens with refer-
ence to contributory burden and healthcare provided.
Irregular immigrants, that is, without stay permit, can be
assisted as ‘temporarily present foreigners’: they are pro-
vided a special card that ensures basic and specialised
health services. Doctors in emergency services are not
asked to report migrants who have no residence permit
(law 94/2009 ‘Norms on public security’). In
Emilia-Romagna, hospitalisation is lower among immi-
grants than among Italians, for men and women, when
excluding obstetric causes. Even if hospital admissions of
immigrants increased from 3.1% of total in 2002 to
7.4% in 2009, the number continues to be lower com-
pared with hospital admissions of residents. However,
immigrants tend to have more frequently urgent hospita-
lisations, probably due to limited knowledge of commu-
nity health services and general practitioners.14
Definition of multimorbidity
No standard approach for the measurements of multi-
morbidity exists, and selection and definition of the dis-
eases to be considered is inevitably subjective and
dependent on the data available.2 In the present study,
we sought to identify all diseases recommended as core
for any multimorbidity measure in a systematic review,15
and which are likely to have a significant impact on
patients in terms of need for chronic treatment,
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reduced function, reduced quality of life and risk of
future morbidity and mortality. However, in Italy, elec-
tronic clinical records for primary care are not available
because general practitioners are not requested to
collect information about diseases. Thus, we tracked the
presence of a number of diseases using information on
hospital discharges, contacts with community mental
health services and accredited residential facilities, and
drug prescriptions.
Specifically, 16 physical illnesses were defined using
the comorbidity ICD-9-CM coding algorithms developed
by Charlson et al16 and Elixhauser et al,17 and enhanced
by Quan et al,18 whereas 10 mental health disorders were
tracked using an ad hoc ICD-9-CM coding algorithm.19
We also used drug prescriptions for tracking hyperten-
sion, diabetes, bipolar disorder, depression and anxiety
—all diseases that, in Italy, are managed to a large
extent by general practitioners. Table 1 provides further
details of definitions and the 26 diseases included in the
study. Complete lists of ICD-9-CM codes and ATC codes
used for defining the 26 diseases are provided in online
supplementary files 1 and 2, respectively. In online
supplementary file 3, we have displayed the percentage
contribution of hospitalisations and drug prescriptions
in defining hypertension, diabetes, bipolar disorder,
depression and anxiety.
As in most other studies,15 we defined multimorbidity
as the co-occurrence of two or more diseases in one
patient.
Statistical analyses
We used graphical displays for descriptive analysis of dif-
ferences in the prevalence of morbidity and multimor-
bidity across age groups and between women and men.
Age- and gender-standardised prevalence of multimor-
bidity among foreign citizens was calculated using the
Italian population resident in the region of
Emilia-Romagna on 31 December 2012 as the standard
population. Differences across age-groups, between
women and men and between Italians and foreigners
were assessed using the χ² test.
The correlations of the 26 conditions were analysed
using exploratory factor analysis, as suggested by Schäfer
et al,20 and using the iterated principal factor method.
We used a tetrachoric correlation matrix for factor ana-
lysis: in doing so, we made the assumption that all the
dichotomous diagnoses (presence or absence of the
disease) reflected an underlying continuous latent trait,
that is, that the chronic conditions included in the mul-
timorbidity count had a progressive course and got diag-
nosed if a certain threshold was reached during this
course. The factors resulting from this analysis can be
interpreted as multimorbidity patterns (ie, clusters of
diagnoses frequently associated with each other), and
each factor loading represents the association of the spe-
cific disease with a pattern. As a measure of model fit,
we reported the proportion of variance of the data
accounted for by the multimorbidity patterns. The
extraction criterion for factors was a minimum eigen-
value of 1. Factor loadings of 0.30 or more were consid-
ered relevant and reported in the results. Since we
assumed that multimorbidity factors were associated with
each other, we used an oblique (oblimin) rotation of
factor loading matrices. Spearman’s ρ was used to
analyse the relationship of factor scores with age, gender
and citizenship.
All analyses were conducted using Stata software, V.13
(StataCorp, 2013, Stata Statistical Software: Release 13,
College Station, Texas, USA: StataCorp LP).
Ethics statement
The study was exempt from approval from the Ethics
Committee of Emilia-Romagna. It was conducted in con-
formity with the regulations for data management from
the Regional Health Authority of Emilia-Romagna, and
with the Italian Code of conduct and professional practice
applying to processing of personal data for statistical and scien-
tific purposes (art. 20–21, legislative decree 196/2003;
http://www.garanteprivacy.it/web/guest/home/docweb/-/
docweb-display/docweb/1115480) published in the
Official Journal no. 190 of August 14, 2004, which expli-
citly exempts the need for approval from the Ethics
Committee when using anonymous data (Preamble
number 8).
In Italy, anonymous administrative data-gathering is
subject to the law Protection of individuals and other subjects
with regard to the processing of personal data, ACT no. 675 of
31.12.1996 (amended by Legislative Decree no. 123 of
09.05.1997, no. 255 of 28.07.1997, no. 135 of 08.05.1998,
no. 171 of 13.05.1998, no. 389 of 6.11.1998, no. 51 of
26.02.1999, no. 135 of 11.05.1999, no. 281 of 30.07.1999,
no. 282 of 30.07.1999 and no. 467 of 28.12.2001)
(http://www.privacy.it/legge675encoord.html).
Data were anonymised prior to the analysis at the
regional statistical office, and each patient was assigned
a unique identifier that eliminates the ability to trace
the patient’s identity or other sensitive data. As anon-
ymised administrative data are used routinely for health-
care management, no specific written informed consent
was needed to use the patient information.
All procedures performed in this study were in accord-
ance with the 1964 Helsinki Declaration and its later
amendments.
RESULTS
We analysed data from 3 759 836 adults residing in the
region of Emilia-Romagna on 31 December 2012
(women: 1 956 857, 52.0%; aged ≥65 years: 1 018 053,
27.1%; immigrants: 422 834, 11.2%). A total of 2 386
799 participants (63.5%) had no disease, whereas
798 829 (21.2%) had one disease and 574 208 (15.3%)
two or more diseases. The demographic characteristics
of the study population (ie, patients with one or more
diseases) are provided in table 2. The mean number of
diseases by age, gender and citizenship is also reported.
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Figure 1 shows the prevalence of each disease by gender.
The prevalence of hypertension (men: 27.8%, women:
31.1%; χ²=4700, p<0.001), depression (2.6%, 5.9%;
χ²=25 000, p<0.001), anxiety (0.8, 1.5%; χ²=3800, p<0.001),
dementia (0.8%, 1.4%; χ²=3500, p<0.001) and dysthymia
(0.5%, 1.2%; χ²=5900, p<0.001) was higher among women,
whereas diabetes (6.6%, 5.4%; χ²=2200, p<0.001), chronic
pulmonary disease (2.8%, 2.1%; χ²=1800, p<0.001), myo-
cardial infarction (2.4%, 1.0%; χ²=12 000, p<0.001), per-
ipheral vascular disease (1.9%, 0.9%; χ²=7700, p<0.001)







Myocardial infarction Diagnosis code ever recorded Physical 2003–2012 HDR
Congestive heart failure Diagnosis code ever recorded Physical 2003–2012 HDR
Peripheral vascular disease Diagnosis code ever recorded Physical 2003–2012 HDR
Cerebrovascular disease Diagnosis code ever recorded Physical 2003–2012 HDR
Hypertension Diagnosis code ever recorded or
≥2 antihypertensive prescriptions
over 12 months
Physical 2003–2012 HDR, OPD
Dementia, including Alzheimer’s
disease




Chronic pulmonary disease Diagnosis code ever recorded Physical 2003–2012 HDR
Rheumatic disease Diagnosis code ever recorded Physical 2003–2012 HDR
Peptic ulcer disease Diagnosis code ever recorded Physical 2003–2012 HDR
Liver disease Diagnosis code ever recorded Physical 2003–2012 HDR
Diabetes Diagnosis code ever recorded or
≥2 antidiabetic prescriptions over
12 months
Physical 2003–2012 HDR, OPD
Paralysis Diagnosis code ever recorded Physical 2003–2012 HDR
Other neurological disorders Diagnosis code ever recorded Physical 2003–2012 HDR
Renal disease Diagnosis code ever recorded Physical 2003–2012 HDR
Any malignancy, including lymphoma
and leukaemia, except malignant
neoplasm of skin
Diagnosis code ever recorded Physical 2008–2012 HDR
Metastatic solid tumour Diagnosis code ever recorded Physical 2008–2012 HDR
AIDS/HIV Diagnosis code ever recorded Physical 2003–2012 HDR
Schizophrenia and psychosis Diagnosis code ever recorded Mental 2003–2012 HDR, MHIS,
RMHDR
Bipolar disorder Diagnosis code ever recorded or
≥4 lithium prescriptions over 12
months
Mental 2003–2012 HDR, MHIS,
RMHDR, OPD
Depression Diagnosis code ever recorded or
≥4 antidepressant prescriptions
over 12 months
Mental 2012 HDR, MHIS,
RMHDR, OPD
Dysthymia Diagnosis code ever recorded Mental 2003–2012 HDR, MHIS,
RMHDR
Anxiety, dissociative and somatoform
disorders
Diagnosis code ever recorded or
≥4 anxiolytic/hypnotic prescriptions
over 12 months
Mental 2012 HDR, MHIS,
RMHDR, OPD
Personality disorders Diagnosis code ever recorded Mental 2003–2012 HDR, MHIS,
RMHDR
Substance use disorders Diagnosis code ever recorded Mental 2003–2012 HDR, MHIS,
RMHDR
Intellectual disabilities Diagnosis code ever recorded Mental 2003–2012 HDR, MHIS,
RMHDR
Other mental disorders Diagnosis code ever recorded Mental 2003–2012 HDR, MHIS,
RMHDR
For conditions which have lifelong implications such as diabetes, we defined the presence of the condition on the basis of a diagnosis code
ever being recorded between 2003 and 2012. For malignancies, depression and anxiety, we defined the presence of the morbidity in a
shorter observation period. For MHIS and RMHDR databases, the observation period starts 2005 and 2008, respectively.
HDR, hospital discharge record; MHIS, mental health information system; OPD, outpatient pharmaceutical database; RMHDR, residential
mental healthcare discharge record.
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and renal disease (1.1%, 0.7%; χ²=1800, p<0.001) were
more common among men. Figure 2 shows the preva-
lence of the 26 diseases by age group—dark blocks repre-
sent high prevalence values, whereas light blocks
represent low prevalence values. The prevalence of all
diseases increased with age, with the exception of AIDS/
HIV and some psychiatric disorders (schizophrenia and
psychosis, bipolar disorder, personality disorders, sub-
stance use disorders and intellectual disabilities and
other mental disorders).
On 31 December 2012, in Emilia-Romagna, patients
with a single disease were 798 829 (21.2%), whereas
patients with multimorbidity were 574 208 (15.3%). The
prevalence of morbidity differed significantly by gender
(men: 19.4%, women: 22.9%; χ²=25 000, p<0.001), as
well as the prevalence of multimorbidity (men: 15.1%,
women: 15.4%; χ²=85.38, p<0.001). However, in this
latter case, the significance of the test seemed to be
caused by the large size of the study population, rather
than by the actual difference between the two preva-
lence values.
The proportion of people with multimorbidity
increased significantly with age (figure 3), from 19.1%
in those aged 60–64 years up to 60.8% in the ≥90-year
group (χ² for trend=700 000, p<0.001); among old
patients (aged ≥65 years), the proportion of multimor-
bidity was 39.9%. Italian citizens with a single disease
were 19.9% and those with multimorbidity were 14.4%,
whereas among immigrants these prevalence values,
standardised by gender and age, were significantly lower
(15.0% and 9.3%, respectively, χ²=8200, p<0.001).
Exploratory factor analysis of diseases identified five
patterns (table 3). The first factor includes psychiatric
disorders; the second factor includes cardiovascular,
renal, pulmonary and cerebrovascular diseases; the third
factor comprises neurological diseases; the fourth factor
includes liver diseases, AIDS/HIV and substance abuse;
the fifth factor includes tumours. As for the association
between factor scores and demographic characteristics,
we found that the only correlation coefficient close to
0.30 was that between multimorbidity pattern 2 and age
(Spearman’s ρ=0.27, p<0.001), indicating that the pres-
ence of cardiovascular, renal, pulmonary and/or cere-
brovascular diseases was more common among older
than younger age groups.
DISCUSSION
In this population-based cross-sectional study, one of the
six adults were multimorbid, whereas among older
people (aged ≥65 years) this proportion was more than
one of three. This result is consistent with the range of
prevalence values found in other studies on multimor-
bidity,21–23 although very close to the lower boundary of
this range (12.9% for participants aged ≥18 years). A
possible explanation is that administrative databases
contain only information about people seeking treat-
ment in public services and accredited facilities.
Therefore, a prevalence of 15.3% only reflects attended
morbidity. Another reason for this results is the lack of a
more comprehensive selection of diagnoses, including
other relevant conditions mentioned in systematic
reviews. It is also worth noting that, in line with other
studies,24–26 the proportions of men and women pre-
senting more than one chronic disease were very similar.
The Italian National Institute of Statistics (Istat)
reported that, in 2012, multimorbidity affected 20.4% of
the Italian population (49.4% in participants aged
54–74 years and 69.4% in participants aged ≥90 years)
(http://www.istat.it/it/archivio/5471). These figures
Table 2 Demographic characteristics of the study
population
Demographic







Male 622 026 (45.3) 1.82
Female 751 011 (54.7) 1.73
Age, mean±SD 66.4±15.3
Age group, n (%)
18–24 11 290 (0.8) 1.33
25–29 11 427 (0.8) 1.35
30–34 18 408 (1.3) 1.36
35–39 32 945 (2.4) 1.37
40–44 52 746 (3.8) 1.38
45–49 78 260 (5.7) 1.41
50–54 100 065 (7.3) 1.44
55–59 119 252 (8.7) 1.48
60–64 146 964 (10.7) 1.56
65–69 162 103 (11.8) 1.66
70–74 179 168 (13.0) 1.79
75–79 169 422 (12.3) 1.98
80–84 141 493 (10.3) 2.19
85–89 97 494 (7.1) 2.39
≥90 52 000 (3.8) 2.47
Citizenship, n (%)
Italian 1 321 716 (96.3) 1.78
Non-Italian 51 321 (3.7) 1.40
European Union 9834 (19.2) 1.40
Central and Eastern
Europe
16 982 (33.1) 1.38
Other European countries 481 (0.9) 1.80
North Africa 8433 (16.4) 1.46
West Africa 4533 (8.8) 1.34




Western Asia 428 (0.8) 1.44
Central and Southern Asia 4251 (8.3) 1.45
East Asia 3123 (6.1) 1.33
Northern America 120 (0.2) 1.67
Latin America 2066 (4.0) 1.45
Oceania 13 (0.03) 1.62
Unknown 316 (0.6) 1.51
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differ from those presented in this study for two possible
reasons: first, Istat included in multimorbidity count
some chronic diseases that we did not detect (ie, celiac
disease, allergies, migraine and osteoporosis); second,
the Istat survey is based on self-reported information,
thus possibly overestimating the prevalence of some
chronic health diseases.
When we examined each disease separately we found,
consistently with other studies, that hypertension, dia-
betes and depression were highly prevalent,27 28 with
some variation between genders (ie, hypertension and
depression more common among women, and diabetes
more common among men). In general, we found a
high prevalence of hypertension, diabetes, depression,
cerebrovascular disease, non-metastatic tumours, chronic
pulmonary disease, congestive heart failure and myocar-
dial infarction—all diseases that, according to the litera-
ture, should be included in every multimorbidity
index.15 29
As expected, we found that multimorbidity was
strongly associated with increasing age. This finding cor-
roborates many other studies2 3 30 31 and may be
explained by the longer exposure and increased vulner-
ability in older persons to risk factors for chronic health
problems.3 Age-related multimorbidity has major finan-
cial and social implications, as populations are rapidly
ageing in most countries, including developing coun-
tries and those in transition. Indeed, the burden of
chronic disease is the biggest financial challenge to
countries and healthcare systems worldwide.32
Of interest, immigrants had fewer diseases than Italian
citizens. A possible explanation is that immigrants, pre-
sumably of first generation and looking for manual jobs
that require intense physical work, are on average
healthier than native-born. This phenomenon has been
defined as the ‘healthy immigrant effect’.33 34 However,
it is more plausible that these figures reflect the well-
known lower access of immigrants to healthcare and par-
ticularly specialist healthcare.35
Using factor analysis, we identified some relevant
disease patterns. Comparing our results with those of
other studies is difficult because of different diseases,
data sources, populations and setting considered. Still,
like Islam et al,28 we found the tumours constitute a dis-
tinct pattern, probably because risk factors for cancer
may be specific. Moreover, similarly to many other
studies,21 26 27 36 37 we found a strong association
between cardiovascular, renal, pulmonary and cerebro-
vascular diseases, suggesting that this pattern is part of
the natural biological and pathological course of these
illnesses, such as inflammation, hypoxia, oxidative stress
or ageing, and is related to general risk factors such as
smoking or pollution.38 In line with Barnett et al,2 we
also found that psychiatric disorders tended to correlate
with each other and were not associated with age.
Finally, we found a multimorbidity pattern composed of
Figure 1 Prevalence values (%) of single diseases by gender.
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Figure 2 Prevalence values (%) of single diseases by age group. Notes: Dark blocks represent high prevalence values,
whereas light blocks represent low prevalence values. Cut-points of percentiles are displayed in the legend.
Figure 3 Number of chronic diseases by age group. Notes: Red dots indicate the prevalence of multimorbidity by age group.
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liver diseases (ie, chronic hepatitis and cirrhosis), AIDS/
HIV and substance use, which is consistent with evidence
that liver and infective diseases are common in patients
with substance use disorder.
Our results provide useful insights as regards the
implementation of healthcare policies and the organisa-
tion of healthcare services. Although the evidence base
for the management of multimorbidity appears to be
thin and much more research is still needed,8 it is now
well recognised that best practice should focus on the
prevention of common risk factors and an orientation of
treatment towards the improvement of functional limita-
tions.21 These are core functions of primary care profes-
sionals, and particularly of generals practitioners, who
are asked to have a broad knowledge base, be able to
coordinate care across a range of different specialist ser-
vices, have good judgement to balance competing prior-
ities, inquire about patient preferences during a
consultation and, as a whole, refine the treatment to
multimorbid patients to promote better and more con-
sistent management and self-management of the ill-
nesses.6 9 39 Therefore, the high prevalence of
Table 3 Multimorbidity patterns derived from factor analysis
Multimorbidity pattern













Eigenvalue 4.42 3.37 1.89 1.34 1.04
Proportion of variance 0.37 0.28 0.15 0.11 0.09
Cumulative proportion 0.37 0.65 0.80 0.91 1.00
Condition
Personality disorders 0.77 0.34
Bipolar disorder 0.74






Other mental disorders 0.43
Congestive heart failure 0.80
Renal disease 0.67
Peripheral vascular disease 0.61
Myocardial infarction 0.56
Chronic pulmonary disease 0.54
Cerebrovascular disease 0.505 0.504





















Correlation (Spearman’s ρ) with:
Age 0.08 0.27 0.04 −0.15 0.02
Female 0.10 −0.12 0.04 −0.09 0.03
Non-Italian citizenship −0.02 −0.01 −0.01 0.05 −0.004
Factor loadings<0.30 are not reported.
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multimorbidity in older patients underscores the urgent
need for providing these care interventions on a routine
delivery system.
The identification of clustering of conditions in
patients with multimorbidity is no less important for
three main reasons:21 from an aetiological perspective,
to understand what makes conditions tend to co-occur
with the aim to prevent their development in the first
place; from a clinical perspective, to identify therapeutic
approaches that allow the tailoring of care for significant
strata of people with a given condition or combination
of conditions and from a policy perspective, to target
more common disease combinations and orient the
delivery of care with the aim to ensure that the resources
match the needs of patients of the same cluster.
The implications of our study need to be interpreted in
light of the study’s limitations. First, the use of administra-
tive data may have underestimated multimorbidity. In
fact, during the observation period, a number of partici-
pants suffering from chronic diseases (in particular psy-
chiatric disorders) may have never sought care, been
hospitalised or been prescribed long-term drug therap-
ies. Moreover, the underestimation of multimorbidity
may have been differential, that is, more pronounced for
some patients rather than others (presumably older
people and immigrants). However, in order to improve
the accuracy of our estimates, we extended the observa-
tion period to several years and integrated different data
sources, including hospital records and prescriptions, as
suggested by other authors.40 41 Second, we did not use
antipsychotic prescriptions to identify patients with
dementia because these drugs are quite non-specific in
their effect and are commonly prescribed also for a large
number of severe psychiatric disorders, including schizo-
phrenia, mania, agitated psychotic depression and para-
noid disorders. Third, hypertension and depression were
traced using some drugs that are prescribed also for heart
failure, ischaemic heart disease and neuropathic pain,
thus increasing the sensitivity of the disease count but
lowering the specificity. Fourth, it is possible that a study
period of 10 years, from 2003 to 2012, was not long
enough to detect thoroughly all chronic diseases, espe-
cially for the elderly, once again possibly underestimating
the number of morbid and multimorbid patients; an
excessively long observation period, however, may lead to
the inclusion of conditions with a prolonged course but
which are not active at the time of the study.23 It is also
worth noting that our study included the periods preced-
ing and following the global financial crisis, and this may
have overestimated the prevalence of some diseases
which we investigated only in the post-crisis period such
as depression and anxiety; for the same reason, estimates
may have been inflated to some degree for younger
people. Fifth, we did not include in the multimorbidity
count a number of relevant conditions mentioned in sys-
tematic reviews, such as osteoporosis, angina, arthritis,
cardiac arrhythmia, thyroid disease, anaemia, dyslipidae-
mia and obesity. We are well aware that this issue leads to
an underestimation of multimorbidity and makes com-
parison with other studies difficult; still, our choice was
conditioned by the fact that these diseases are not
present in the algorithms developed by Charlson and
Elixhauser, are managed to a large extent by general
practitioners and are characterised by differences and
variety in the case definition. For all these reasons, the
multimorbidity prevalence estimates calculated in this
study should be interpreted as the ‘lower boundary’ for
the proportion of participants suffering from two or
more chronic health disorders; to summarise, in
Emilia-Romagna, the prevalence of multimorbid adults is
not lower than 15% (40% among the elderly).
CONCLUSIONS
We found that multimorbidity was highly prevalent in
Emilia-Romagna and strongly associated with age. We
also found five predominant combinations of chronic
conditions, suggesting that single disease-oriented clin-
ical guidelines and pathways of care may be less effective
than patient-centred care. These findings highlight the
importance of planning studies that evaluate the impact
of multimorbidity on health outcomes, costs and quality
of care, and confirm the need for healthcare providers
to promote access to healthcare, adopt individualised
care plans and ensure continuity of care for patients
who suffer from multiple chronic conditions.
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